[DPHARMA] YoY TTM Result on 30-Jun-2011 [#2]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
18-Aug-2011
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2011
Quarter
30-Jun-2011 [#2]
Profit Trend
QoQ- -1.27%
YoY- 6.91%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
TTM Result
30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 CAGR
Revenue 167,697 140,724 140,215 134,988 126,816 123,622 120,724 5.62%
PBT 39,496 39,354 35,468 35,995 34,460 35,047 41,837 -0.95%
Tax -7,519 -9,526 -8,043 -6,906 -7,251 -7,476 -9,988 -4.62%
NP 31,977 29,828 27,425 29,089 27,209 27,571 31,849 0.06%
-
NP to SH 31,977 29,828 27,425 29,089 27,209 27,571 31,849 0.06%
-
Tax Rate 19.04% 24.21% 22.68% 19.19% 21.04% 21.33% 23.87% -
Total Cost 135,720 110,896 112,790 105,899 99,607 96,051 88,875 7.30%
-
Net Worth 179,145 187,404 162,310 154,198 140,286 136,061 129,067 5.61%
Dividend
30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 CAGR
Div 24,291 20,128 24,980 5,014 22,910 9,814 58,277 -13.56%
Div Payout % 75.97% 67.48% 91.09% 17.24% 84.20% 35.60% 182.98% -
Equity
30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 CAGR
Net Worth 179,145 187,404 162,310 154,198 140,286 136,061 129,067 5.61%
NOSH 138,872 138,818 138,727 138,917 138,897 138,837 138,782 0.01%
Ratio Analysis
30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 CAGR
NP Margin 19.07% 21.20% 19.56% 21.55% 21.46% 22.30% 26.38% -
ROE 17.85% 15.92% 16.90% 18.86% 19.40% 20.26% 24.68% -
Per Share
30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 CAGR
RPS 120.76 101.37 101.07 97.17 91.30 89.04 86.99 5.61%
EPS 23.03 21.49 19.77 20.94 19.59 19.86 22.95 0.05%
DPS 17.50 14.50 18.00 3.61 16.50 7.06 42.00 -13.57%
NAPS 1.29 1.35 1.17 1.11 1.01 0.98 0.93 5.60%
Adjusted Per Share Value based on latest NOSH - 138,917
30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 CAGR
RPS 17.43 14.63 14.58 14.03 13.18 12.85 12.55 5.62%
EPS 3.32 3.10 2.85 3.02 2.83 2.87 3.31 0.05%
DPS 2.53 2.09 2.60 0.52 2.38 1.02 6.06 -13.54%
NAPS 0.1862 0.1948 0.1687 0.1603 0.1458 0.1414 0.1342 5.60%
Price Multiplier on Financial Quarter End Date
30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 CAGR
Date 30/06/14 28/06/13 29/06/12 30/06/11 30/06/10 30/06/09 30/06/08 -
Price 2.97 2.38 2.23 2.34 2.45 2.13 2.48 -
P/RPS 2.46 2.35 2.21 2.41 2.68 2.39 2.85 -2.42%
P/EPS 12.90 11.08 11.28 11.17 12.51 10.73 10.81 2.98%
EY 7.75 9.03 8.87 8.95 8.00 9.32 9.25 -2.90%
DY 5.89 6.09 8.07 1.54 6.73 3.31 16.94 -16.13%
P/NAPS 2.30 1.76 1.91 2.11 2.43 2.17 2.67 -2.45%
Price Multiplier on Announcement Date
30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 CAGR
Date 26/08/14 28/08/13 16/08/12 18/08/11 24/08/10 26/08/09 26/08/08 -
Price 3.37 2.44 2.38 2.22 2.45 2.50 2.30 -
P/RPS 2.79 2.41 2.35 2.28 2.68 2.81 2.64 0.92%
P/EPS 14.64 11.36 12.04 10.60 12.51 12.59 10.02 6.52%
EY 6.83 8.81 8.31 9.43 8.00 7.94 9.98 -6.12%
DY 5.19 5.94 7.56 1.63 6.73 2.82 18.26 -18.90%
P/NAPS 2.61 1.81 2.03 2.00 2.43 2.55 2.47 0.92%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment